Cite

HARVARD Citation

    Calabretta, E. et al. (2022). Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics. British journal of haematology. pp. 82-92. [Online]. 
  
Back to record